Avian Influenza
U.S. Department of Health & Human Services funds advanced development of H5N1 influenza vaccines
Published in Medical Letter on the CDC and FDA, February 18th, 2007
An adjuvant is a substance that may be added to a vaccine to increase the body's immune response to the vaccine's active ingredient, called antigen.
"In the event of an influenza pandemic, a vaccine that uses adjuvant could provide a way to extend a limited vaccine supply to more people," Secretary Leavitt said. "These contracts are a continuation of our aggressive multipronged...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Hemosiderosis Therapy
Research reports from Center for Drug Evaluation and Research provide new insights into hemosiderosis therapy - Acromegaly
Tercica reports NDA for Somatuline Autogel for acromegaly accepted for filing by U.S. FDA - Angiology
ProRhythm initiates U.S. pivotal trial for HIFU ablation system - Antipsychotics
Evidence lacking to support many off-label uses of atypical antipsychotics - Avian Influenza
Tuttle joins HepaLife to expedite development of bird flu vaccine - Bronchiectasis
Aradigm gets U.S. FDA orphan drug status for liposomal ciprofloxacin for lung infection - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
